- ISIN
- US38246G1085
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Sep 23, 2020
Highlights
- Market Cap
- $877.46M
- Enterprise Value
- $710.65M
- EPS (TTM)
- $0.09
- PE Ratio
- 30.22
- PEG Ratio
- 0.26
- Total Revenue (TTM)
- $787.89M
- Gross Profit (TTM)
- $638.38M
- EBITDA (TTM)
- $153.80M
- Year Range
- $1.77 - $5.81
- Target Price
- $3.19
- ROA (TTM)
- 1.46%
- ROE (TTM)
- 4.74%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GDRX Performance Chart
GoodRx Holdings, Inc. (GDRX) is down 5.2% since the beginning of the year. At $3 per share, GDRX is trading 55.8% below its 52-week high of $6. Investors who bought $1,000 worth of GDRX shares 5 years ago would now be looking at an investment worth $67.
Loading charts...
Returns By Period
GoodRx Holdings, Inc. (GDRX) has returned -5.17% so far this year and -44.13% over the past 12 months.
GoodRx Holdings, Inc.
- 1D
- -3.38%
- 1M
- -3.02%
- YTD
- -5.17%
- 6M
- -5.17%
- 1Y
- -44.13%
- 3Y*
- -22.21%
- 5Y*
- -41.72%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
GDRX Monthly Returns History
Based on dividend-adjusted daily data since Sep 23, 2020, GDRX's average daily return is -0.09%, while the average monthly return is -2.45%.
Historically, 40% of months were positive and 60% were negative. The best month was Jul 2023 with a return of +67.4%, while the worst month was May 2022 at -41.2%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.
On a daily basis, GDRX closed higher 46% of trading days. The best single day was Aug 18, 2025 with a return of +37.3%, while the worst single day was Mar 1, 2022 at -38.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -16.24% | -17.62% | 4.81% | 20.41% | 23.73% | -11.99% | -5.17% | ||||||
| 2025 | 2.58% | 4.40% | -11.45% | 4.99% | -15.33% | 27.04% | -3.82% | -9.19% | -2.76% | -20.33% | -16.62% | -3.56% | -41.72% |
| 2024 | -10.45% | 29.83% | -8.86% | -0.00% | 10.85% | -0.89% | 16.03% | -12.71% | -12.15% | -11.82% | -20.92% | -3.93% | -30.60% |
| 2023 | 19.96% | -5.37% | 18.15% | -25.28% | 16.27% | 1.66% | 67.39% | -29.33% | -13.78% | -12.43% | 21.50% | 11.85% | 43.78% |
| 2022 | -26.53% | 14.12% | -29.45% | -29.90% | -41.18% | -25.72% | 5.24% | -2.09% | -23.44% | 14.99% | -18.81% | 6.88% | -85.74% |
| 2021 | 15.57% | -4.50% | -12.35% | 2.54% | -7.25% | -2.96% | -10.94% | 18.55% | 7.89% | 8.73% | -10.49% | -18.14% | -18.99% |
Benchmark Metrics
GoodRx Holdings, Inc. has an annualized alpha of -39.41%, beta of 1.67, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since September 23, 2020.
- This stock participated in 186.60% of S&P 500 Index downside but only -25.86% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -39.41%
- Beta
- 1.67
- R²
- 0.15
- Upside Capture
- -25.86%
- Downside Capture
- 186.60%
Return for Risk
Risk / Return Rank
GDRX ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GoodRx Holdings, Inc. (GDRX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GDRX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.63 | ||
| Sortino ratioReturn per unit of downside risk | -3.43 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.37 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.70 | 2.78 | -3.48 |
| Martin ratioReturn relative to average drawdown | -1.06 | 12.44 | -13.50 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the GoodRx Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GoodRx Holdings, Inc. was 96.73%, occurring on Feb 27, 2026. The portfolio has not yet recovered.
The current GoodRx Holdings, Inc. drawdown is 95.50%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -96.73%Feb 2026 | 5y 4mo | — | 5y 8moOct 2020 - now |
2020 correction2020 | -14.16%Oct 2020 | 3d | 4d | 7dSep 2020 - Oct 2020 |
2020 pullback2020 | -7.52%Sep 2020 | 0s | 1d | 1dSep 2020 - Sep 2020 |
Drawdown Indicators
| GDRX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.73% | -56.78% | -39.95% |
Max Drawdown (1Y)Largest decline over 1 year | -63.48% | -9.10% | -54.38% |
Max Drawdown (3Y)Largest decline over 3 years | -79.76% | -18.90% | -60.86% |
Max Drawdown (5Y)Largest decline over 5 years | -96.03% | -25.43% | -70.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -95.50% | -1.80% | -93.70% |
Average DrawdownAverage peak-to-trough decline | -75.04% | -10.71% | -64.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.64% | 2.03% | +39.61% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of GoodRx Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how GoodRx Holdings, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GDRX, comparing it with other companies in the Health Information Services industry. Currently, GDRX has a P/E ratio of 30.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for GDRX compared to other companies in the Health Information Services industry. GDRX currently has a PEG ratio of 0.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GDRX relative to other companies in the Health Information Services industry. Currently, GDRX has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GDRX in comparison with other companies in the Health Information Services industry. Currently, GDRX has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with GDRX
Add GoodRx Holdings, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GDRX